Switch to हिंदी

Health, Fitness, Beauty & Diet | Pregnancy & Parenting | Diseases & Home Remedies | TheHealthSite.com

Health, Fitness, Beauty & Diet | Pregnancy & Parenting | Diseases & Home Remedies | TheHealthSite.com

हिंदी
  • Health A-Z
  • Diabetes
  • Diseases
    • Type 1 Diabetes
    • Type 2 Diabetes
    • Cancer
    • Heart Attack
    • Pneumonia
    • Diseases A-Z
  • Diet & Fitness
    • Weight Management
    • Exercise & Body Building
    • Diet & Recipes
    • Yoga
  • Coronavirus
  • News
  • Pregnancy
    • Conceiving
    • Infertility
    • Labour & Delivery
    • Pregnancy week-by-week
    • Breastfeeding
    • Baby Names
  • Beauty
    • Skin
    • Hair
    • Grooming
  • Photos
  • Videos
Home / Diseases & Conditions / ‘Compulsory licence verdict a triumph for humanity’

‘Compulsory licence verdict a triumph for humanity’

In what has been billed as landmark ruling the Intellectual Property Appellate Board upheld the country's first compulsory licence to NATCO Pharma for Bayer's cancer drug Nexavar recently. In layman l

By: Ankita Chakrabarty   | | Updated: August 6, 2013 11:57 am
Tags: Bayer  Big Pharma  Cancer drugs  Compulsory licensing  Indian Patent Office  IPAB  Natco  Natco Pharma  Nexavar  

pharma-legalIn what has been billed as landmark ruling the Intellectual Property Appellate Board upheld the country’s first compulsory licence to NATCO Pharma for Bayer’s cancer drug Nexavar recently. In layman language, NATCO, an Indian pharmaceutical company had been the given the right to copy and sell Bayer’s cancer drug Nexavar which costs Rs 2.8 lakh per month. NATCO will sell it for Rs 8,880 per month (97% price decrease)! Team Zee Research Group (ZRG) took the opportunity to understand the ramifications of the verdict from Natco Pharma director and chief financial officer P Bhaskara Narayana. Welcoming the judgment, Narayana is of the view that it is a recognition of the importance of human values over commercial considerations. Also Read - Popping aspirin and other ways to prevent bowel cancer

Also Read - Less chemotherapy effective for older patients with stomach cancer



ZRG: Indian patent appeals board (IPAB) has ruled in favour of Natco Pharma which allows it to sell generic version of Bayer AG’s cancer drug Nexavar. What is your take on this ruling? Also Read - This new device grabs cancer cells from blood

PBN: We welcome this ruling as it recognises the importance of human values more than the commercial values.

ZRG: Post IPAB verdict, the royalty level has been increased from 6 to 7 per cent. How will that impact the margins of the company?

PBN: We are already paying a 6 per cent royalty so a per cent increase won’t have any significant impact on the margins.

ZRG: What is the current revenue from Nexavar drug and what sort of revenue growth are you expecting from this drug in the coming years?

PBN: We have sold about Rs 13-14 crore worth of this drug so far this fiscal. In the coming years, we expect this drug to garner revenues between Rs 15 and Rs 20 crore.

ZRG: Can you elaborate on the actual demand-supply scenario for this drug? What percentage of your revenues come from Oncology segment?

PBN: This is something which we can’t elaborate. However, this drug is used to cure kidney and liver patients. It depends on doctor’s prescription and the stage of disease. Our total consolidated revenues is Rs 700 crores and out of that around Rs 150 crore comes from Oncology segment (around 21 per cent of the revenues).

ZRG: In recent times there were series of judicial setbacks for big MNCs involving drug patents (like Novartis case). Do you think that Indian Patent Office is really too harsh on them or it is favouring low cost generic in order to make costly lifesaving drugs affordable?

PBN: I don’t think we have any right to object the Indian Patent Office. In my view, the Indian Patent Office is doing its job.

What is compulsory licensing?

It’s a practice by which a company’s intellectual property rights can be overruled. The WTO-TRIPS 2006 gives developing nations’ governments the right to hand out compulsory licenses in case it deems that the product is too costly for the public. It’s particularly important in drug pricing because it allows local companies the right to create generic versions of drugs and sell them at a lower rate. The Indian Patent office became the first government body to hand out one when they allowed a local pharma to re-engineer an expensive foreign cancer drug and sell it at a cut-price rate.

Tired of reading? Check out our YouTube Channel

Published : March 14, 2013 7:14 pm | Updated:August 6, 2013 11:57 am
Read Disclaimer

10 tips for better sleep (World Sleep Day)

10 tips for better sleep (World Sleep Day)

Antibiotic resistance – why it is more dangerous than you think

Antibiotic resistance – why it is more dangerous than you think

Please Wait. Article Loading ....

Coronavirus Updates

Coronavirus Updates

Stay Informed, Be Safe

  • COVID-19 Unlock: How to ensure students and teachers are safe amid schools reopening
  • Bridging the gap between immunisation and immunity: 2 new diagnostic tests for COVID-19
  • COVID-19 vaccine for people above 60, comorbid people from March 1, free at government centres
  • Americans are less afraid of dying from COVID-19: How Indians perceive coronavirus
  • 54-year-old man dies after taking COVID-19 vaccine Covishield in Delhi

Health Calculators

BMI Calculator
bmi Calculator
Ideal Body Weight
ideal body weight
Daily Calorie Intake
Daily calorie intake
Calories Burned
calories burned

Related Stories

Popping aspirin and other ways to prevent bowel cancer

Popping aspirin and other ways to prevent bowel cancer

Less chemotherapy effective for older patients with stomach cancer

Less chemotherapy effective for older patients with stomach cancer

This new device grabs cancer cells from blood

This new device grabs cancer cells from blood

Aspirin, ibuprofen can improve survival rate of cancer patients, says study

Aspirin, ibuprofen can improve survival rate of cancer patients, says study

New spray gel to help ward off cancer recurrence post-surgery, say researchers

New spray gel to help ward off cancer recurrence post-surgery, say researchers

Health News in Hindi

गर्भवती मां से भ्रूण तक पहुंच सकती हैं प्रोटेक्टिव एंटीबॉडीज़, स्टडी का दावा

Nail Biting Habit: नाखून कुतरने की वजह क्‍या है, जानिए वैज्ञानिक पहलू और इससे छुटकारा पाने के उपाय

सांवली सूरत पर ग्‍लो लाने के लिए मसाबा गुप्‍ता फॉलो करती हैं ये होममेड स्किन केयर रूटीन, आप भी कर सकती हैं ट्राई

अनिल कपूर ने कहा- “खूब खाता हूं बर्गर और फ्रेंच फ्राइस” इसलिए फिटनेस को ऐसे रखता हूं मेनटेन

COVID-19 vaccination for elderly: 60 साल से अधिक आयु वर्ग के लोगों को एक मार्च से मुफ्त में कोरोना वैक्सीन

Read All

Recent Posts

  • Covid-19 can mess up with your sugar levels: Get your glucose levels checked after recovery
  • Woman dies hours after taking second COVID-19 vaccine dose in MP
  • Ladies, up your plant protein intake to lower risk of premature death
  • New study suggests rats, water buffalo and mountain gorillas can spread COVID-19 virus
  • COVID-19 Unlock: How to ensure students and teachers are safe amid schools reopening

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com
+91 – 22 – 6697 1234
Landline Phone number 91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

Useful Links

  • Weight Loss
  • Keto Diet Tips
  • Skin Care Tips
  • Intermittent Fasting
  • Apple Cider Vinegar
  • Ashwagandha
  • Cancer
  • Pneumonia
  • Diarrhoea
  • Dengue
  • Typhoid
  • Tuberculosis
  • Chickenpox
  • Chikungunya
  • Depression
  • Hepatitis
  • Diabetes
  • Type 2 diabetes
  • Arthritis
  • Swine Flu
  • Baby Names
  • Cough and cold
  • Heart Attack
  • Breast Cancer
  • Ebola Virus
  • Dengue
  • Malaria
  • International Yoga Day
  • Hypotension
  • Heart Failure
  • Asthma
  • Brain Tumour
  • Celebrity Fitness
  • Goitre
  • HIV/AIDS

We respect your privacy

  • Disclaimer
  • Privacy Policy
  • Contact Us
  • Author Profiles

Copyright © 2021 Zee Entertainment Enterprises Limited. All rights reserved.